EN DE
Watch Citra Nusantara Gemilang Tbk. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Citra Nusantara Gemilang Tbk. (CGAS) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Citra Nusantara Gemilang Tbk. stock IDR 120, price IDR 115, upside +4.7%, quality 53 out of 100. Rating: fairly valued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Energy ID

CN Citra Nusantara Gemilang Tbk. logo Thin data Nov 4, 2026

Citra Nusantara Gemilang Tbk.

CGAS · JK
Meets all rules: fair value rule, solid quality, uptrend

The stock costs about what our calculation considers fair.

Low debt
Ranks above peers (8/13)
Revenue last quarter +54% vs. a year ago.
Fair value 120.39 IDR · Fairly valued
Quality 53/100
Expensive Growth (revenue 5y +10.1 %/yr in IDR)
Thin margins · 3.2% net margin (TTM)
Negative free cash flow
Narrow moat 36/100 · thin data
Thin data
⟳ Cyclical
Watch Citra Nusantara Gemilang Tbk. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

869.67 IDR 72.75 IDR Fair Value 120.39 IDR Jan 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

34‑month range 72.75 IDR – 869.67 IDR · fair‑value band 91.87 IDR – 148.77 IDR · the 115.00 IDR price screens below the 120.39 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.

Follow Citra Nusantara Gemilang Tbk. in your weekly email

Every Wednesday you see whether Citra Nusantara Gemilang Tbk. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Citra Nusantara Gemilang Tbk, an energy company, engages in the trading and distribution of natural gas in the form of compressed natural gas (CNG) to the industrial, retail, and transportation sectors in Indonesia.

Show moreShow less

The company is also involved in the trading, sale, and installation of gas equipment; engineering, procurement, and construction of CNG stations; vehicle conversion and maintenance; construction, operation, and maintenance of independent power plants; and operation and maintenance of CNG plants.

It offers its products under the GASRA brand. PT Citra Nusantara Gemilang Tbk was founded in 2005 and is headquartered in Bekasi, Indonesia.

Stock analysis

Citra Nusantara Gemilang Tbk. (CGAS) currently trades at 115.00 IDR, while our model-based Fair Value estimate is 120.39 IDR, so the stock looks roughly fairly valued today (gap 4.5%).

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 180.55 IDR per share, and 10 of the 16 models we run sit above the 115.00 IDR price.

Bear case: the Dividend Discount group reads lowest at 32.83 IDR, and 6 of the 16 models stay below the price. Data coverage for this calculation is low.

Scenario range: 91.87 IDR (bear) to 148.77 IDR (bull), the price of 115.00 IDR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Energy sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Citra Nusantara Gemilang Tbk. reported revenue of 612B IDR in FY2026 versus 388B IDR in FY2022, a compound +12.1%/yr. Reported net income was 14.2B IDR in FY2026, compounding +47.7%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.

Key figures

Market cap 204B IDR (≈ $11.3M) Micro · P/E ratio 8.9 · P/S ratio 0.28 · EPS (TTM) 12.99 IDR · Dividend yield 2.2% · Net margin 3.2% · Return on equity 9.1% · Return on assets (EBIT) 5.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (low confidence).

What moves the price

The share trades about 49% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Energy peers we cover trades at −46% fair-value upside, at 5%, CGAS screens cheaper than that median.

Fair Value models

Bear 91.87 IDR Fair Value 120.39 IDR Bull 148.77 IDR
Price 115.00 IDR · Upside +4.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 4 months old). Earnings retained since then (4.70 IDR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income 105.69 IDR 104.13 IDR 108.10 IDR 76
EPV 90.72 IDR 99.09 IDR 105.94 IDR 74
ROIC Compounder 90.72 IDR 99.09 IDR 105.94 IDR 72
All 16 models by family
Earnings-Based
Graham-Dodd 54.56 IDR 326.54 IDR 455.06 IDR 63
Lynch FV 93.01 IDR 132.88 IDR 172.74 IDR 61
PEG = 1.0 93.01 IDR 132.88 IDR 172.74 IDR 57
EPV 90.72 IDR 99.09 IDR 105.94 IDR 74
Dividend Discount
Gordon GGM 19.75 IDR 33.89 IDR 44.80 IDR 68
DDM Multi-Stage 19.75 IDR 31.76 IDR 36.38 IDR 67
Multiples
P/E Multiple 108.32 IDR 144.43 IDR 180.54 IDR 63
P/S Multiple 102.31 IDR 136.41 IDR 170.51 IDR 58
P/B Multiple 201.56 IDR 268.75 IDR 335.93 IDR 55
EV/EBIT 149.50 IDR 196.28 IDR 243.05 IDR 66
EV/EBITDA 122.87 IDR 160.77 IDR 198.67 IDR 67
EV/Revenue 122.68 IDR 171.33 IDR 219.98 IDR 54
Asset-Based
NCAV (Graham) 41.45 IDR 62.80 IDR 78.51 IDR 54
Economic Profit
Residual Income 105.69 IDR 104.13 IDR 108.10 IDR 76
ROIC Compounder 90.72 IDR 99.09 IDR 105.94 IDR 72
Growth Earnings
Growth-Adj P/E 126.39 IDR 180.55 IDR 234.72 IDR 67

The fair value above starts from this blend and is adjusted for a cyclical peak year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 47
How much profit the company makes from its sales and capital
Quality Growth 72
Are margins and returns getting better?
Cashflow 12
Do the profits arrive as real cash?
Financial strength 79
Debt, balance sheet and risk of trouble
Investment 26
Does it invest with discipline instead of growing at any price?
Low Volatility 53
How calm the share price moves, does not count
Price momentum 19
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 6
Distance to the 52-week high, does not count
New shares 90
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 49/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+20.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.1%
Start year 2021 (pandemic)
What shareholders gained per year (last 5 years), in IDR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+43.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+41.3%
Dividend (yield on the price)2.2%
Profit margin 2022 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 4%
2026 sits 75% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

Watch CGAS, get fair value alerts →

Compare Citra Nusantara Gemilang Tbk. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas Refining & Marketing · 115 stocks

Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 53 · Below median
Fair Value upside +4.7% · Above median
Profitability
Return on equity (12 months) 9.1% · Below median
Return on assets 3.6% · Above median
Net margin (12 months) 3.2% · Below median
Operating margin (12 months) 5.1% · Below median
Growth and dividend
Revenue growth (quarter YoY) 54.3% · Top 25%
Dividend yield (12 months) 2.2% · Below median
Balance sheet
Debt / equity 0.05× · Below median

Valuation Multiplesvs Oil & Gas Refining & Marketing median · lower = cheaper

P/E (12 months) 8.9× · Cheaper than median
P/B 0.77× · Cheapest 25%
P/S (12 months) 0.28× · Cheaper than median
EV/EBITDA 3.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)40 · sector 30
FUTURE (revenue growth)100 · sector 100
PAST (return on equity)36 · sector 48
HEALTH (low debt)98 · sector 85
DIVIDEND (yield)44 · sector 65

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Oil & gas

Similar stocks

10 more Oil & Gas Refining & Marketing stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Indian Oil Corporation IOC ₹146.25 ₹245.43 +68% vs CGAS
Bharat Petroleum Corporation BPCL ₹319.90 ₹434.58 +36% vs CGAS
SK Innovation Co 096770 109,400 KRW 134,361 KRW +23% vs CGAS
Reliance Industries Limited RELIANCE ₹1,320 ₹865.31 −34% vs CGAS
HF Sinclair Corporation DINO $97.18 $52.92 −46% vs CGAS
Neste Oyj NESTE €27.45 €11.70 −57% vs CGAS
Formosa Petrochemical Corporation 6505 88.40 TWD 35.53 TWD −60% vs CGAS
Valero Energy Corporation VLO $346.45 $131.30 −62% vs CGAS
Phillips 66 PSX $245.72 $86.38 −65% vs CGAS
Marathon Petroleum Corporation MPC $372.74 $113.66 −70% vs CGAS

Explore undervalued stocks

More undervalued Energy stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Citra Nusantara Gemilang Tbk.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Citra Nusantara Gemilang Tbk. Fair Value". https://www.fairvalue-calculator.com/stock/CGAS

Frequently asked questions

Is Citra Nusantara Gemilang Tbk. (CGAS) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 120.39 IDR versus a price of 115.00 IDR, about +5% upside (fairly valued).
What is the fair value of CGAS?
Our model-based fair value for Citra Nusantara Gemilang Tbk. is 120.39 IDR (as of Nov 4, 2026), built from audited fundamentals. The current price: 115.00 IDR.
What is the quality score of CGAS?
Citra Nusantara Gemilang Tbk. has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Citra Nusantara Gemilang Tbk. (CGAS)?
Our model-based price target is the fair value of 120.39 IDR (as of Nov 4, 2026) from 16 valuation models. Cautious scenario 91.87 IDR, optimistic scenario 148.77 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Citra Nusantara Gemilang Tbk. stock forecast for 2026?
Our models put fair value at 120.39 IDR, about +5% upside versus a price of 115.00 IDR (fairly valued). Cautious scenario 91.87 IDR, optimistic scenario 148.77 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Citra Nusantara Gemilang Tbk. (CGAS)?
Citra Nusantara Gemilang Tbk. reported trailing-twelve-month revenue of about 721B IDR (latest available figure, as of Nov 4, 2026).
Does Citra Nusantara Gemilang Tbk. pay a dividend?
Citra Nusantara Gemilang Tbk. currently shows a dividend yield of 2.22% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Citra Nusantara Gemilang Tbk. (CGAS)?
Citra Nusantara Gemilang Tbk. has a dividend yield of 2.2%.
What is the intrinsic value of Citra Nusantara Gemilang Tbk. (CGAS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Citra Nusantara Gemilang Tbk. it is 120.39 IDR per share (as of Nov 4, 2026), against a price of 115.00 IDR. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Citra Nusantara Gemilang Tbk. stock overvalued or undervalued in 2026?
As of Nov 4, 2026, CGAS trades below its calculated fair value: price 115.00 IDR, fair value 120.39 IDR, a gap of about +5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CGAS?
No. The price is what the market pays today (115.00 IDR); the fair value is what the company's own numbers justify (120.39 IDR). For Citra Nusantara Gemilang Tbk. the two are 5.39 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Citra Nusantara Gemilang Tbk. worth?
The market values Citra Nusantara Gemilang Tbk. at about 204B IDR (market capitalisation, as of Nov 4, 2026). Per share that is 115.00 IDR; our models calculate a fair value of 120.39 IDR per share.
What do the bullish and bearish scenarios say about CGAS?
Our models span a range for Citra Nusantara Gemilang Tbk.: cautious scenario 91.87 IDR, base 120.39 IDR, optimistic 148.77 IDR per share (as of Nov 4, 2026, price 115.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CGAS?
Citra Nusantara Gemilang Tbk. trades at a price-to-earnings ratio of 8.9 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 120.39 IDR is built from several models across several years. Other multiples: P/B 0.8, P/S 0.3, EV/EBITDA 3.0.
How solid is the balance sheet of Citra Nusantara Gemilang Tbk. (CGAS)?
Balance-sheet figures for Citra Nusantara Gemilang Tbk. (as of Nov 4, 2026): return on equity 9.1%, debt of 0.05 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is CGAS from its 52-week high?
Citra Nusantara Gemilang Tbk. trades at 115.00 IDR, about 49% below its 52-week high of 225.56 IDR and 3% above the low of 112.00 IDR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 120.39 IDR is for.
Which stocks are comparable to Citra Nusantara Gemilang Tbk.?
From the same area (Energy) we also value Reliance Industries Limited, Valero Energy Corporation, Phillips 66, Marathon Petroleum Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Citra Nusantara Gemilang Tbk. stock attractive at the current price?
The data as of Nov 4, 2026: price 115.00 IDR, calculated fair value 120.39 IDR (+5%), Quality Score 53/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CGAS calculated?
We run Citra Nusantara Gemilang Tbk. through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 120.39 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Citra Nusantara Gemilang Tbk. currently trades 4% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Citra Nusantara Gemilang Tbk. (CGAS)?
The closing price on Nov 6, 2026 was 115.00 IDR. Our model-based fair value is 120.39 IDR, about +5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Citra Nusantara Gemilang Tbk. right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Citra Nusantara Gemilang Tbk.

How large is the market capitalisation of Citra Nusantara Gemilang Tbk. (CGAS)?
The market capitalisation of Citra Nusantara Gemilang Tbk. is 204B IDR (≈ $11.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Citra Nusantara Gemilang Tbk. (CGAS)?
The price-to-sales ratio of Citra Nusantara Gemilang Tbk. is 0.28 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Citra Nusantara Gemilang Tbk. (CGAS)?
Earnings per share at Citra Nusantara Gemilang Tbk. are 12.99 IDR (price ÷ EPS = P/E 8.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Citra Nusantara Gemilang Tbk. (CGAS)?
The dividend yield of Citra Nusantara Gemilang Tbk. is 2.2% (payout 19.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Citra Nusantara Gemilang Tbk. (CGAS)?
The net margin of Citra Nusantara Gemilang Tbk. is 3.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Citra Nusantara Gemilang Tbk. (CGAS)?
The return on equity (ROE) of Citra Nusantara Gemilang Tbk. is 9.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Citra Nusantara Gemilang Tbk. (CGAS)?
On an EBIT basis the return on assets of Citra Nusantara Gemilang Tbk. is 5.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Citra Nusantara Gemilang Tbk. (CGAS)?
The operating margin of Citra Nusantara Gemilang Tbk. is 5.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Citra Nusantara Gemilang Tbk. (CGAS)?
Revenue at Citra Nusantara Gemilang Tbk. is growing +54.3% versus a year earlier (3y avg +13.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Citra Nusantara Gemilang Tbk. (CGAS)?
Earnings per share at Citra Nusantara Gemilang Tbk. are growing +12.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Citra Nusantara Gemilang Tbk. (CGAS) generate?
The free cash flow of Citra Nusantara Gemilang Tbk. is −23.3B IDR (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Citra Nusantara Gemilang Tbk. (CGAS) hold?
Citra Nusantara Gemilang Tbk. holds more cash than debt, 16.2B IDR net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Citra Nusantara Gemilang Tbk. in the live analysis

One click puts Citra Nusantara Gemilang Tbk. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.